Zhixian Wu
Impact in
- Genetics top 5%
- Mesenchymal stem cell research
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
Papers in
- Surgery 20
- Pancreatic function and diabetes 8
- Organ Transplantation Techniques and Outcomes 6
- Co-authors
- Ming Jen Tan (18 shared papers)Jinquan Cai (9 shared papers)E. C. Hsia (1 shared paper)Sudha Visvanathan (1 shared paper)Mahboob U. Rahman (1 shared paper)William Palmer (1 shared paper)J Pazdur (1 shared paper)Sang‐Cheol Bae (1 shared paper)
- Journals
- Cytotherapy (4 papers)Frontiers in Oncology (3 papers)Stem Cell Research & Therapy (2 papers)BioMed Research International (2 papers)Organic Chemistry Frontiers (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhixian Wu
66 papers receiving 1.8k citations
Zhixian Wu's Hit Papers
Peers
Comparison fields: 5 of 115
- Genetics 341
- Rheumatology 381
- Hematology 230
- Hepatology 117
- Transplantation 38
Countries citing papers authored by Zhixian Wu
This map shows the geographic impact of Zhixian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixian Wu more than expected).
Fields of papers citing papers by Zhixian Wu
This network shows the impact of papers produced by Zhixian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixian Wu. The network helps show where Zhixian Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhixian Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study Hit paper breakdown → | 2008 | 432 |
| 2 | 2015 | 134 | |
| 3 | 2019 | 105 | |
| 4 | 2020 | 92 | |
| 5 | 2017 | 90 | |
| 6 | 2017 | 85 | |
| 7 | 2022 | 59 | |
| 8 | 2020 | 59 | |
| 9 | 2020 | 52 | |
| 10 | 2011 | 51 | |
| 11 | 2013 | 51 | |
| 12 | 2024 | 42 | |
| 13 | 2022 | 31 | |
| 14 | 2013 | 28 | |
| 15 | 2020 | 25 | |
| 16 | 2019 | 25 | |
| 17 | 2014 | 21 | |
| 18 | 2008 | 21 | |
| 19 | 2023 | 20 | |
| 20 | 2022 | 19 |
About Zhixian Wu
Zhixian Wu is a scholar working on Surgery, Molecular Biology, Genetics, Electrical and Electronic Engineering and Hepatology, having authored 72 papers that have together received 1.8k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (12 papers), Pancreatic function and diabetes (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Advanced battery technologies research (7 papers), Renal Transplantation Outcomes and Treatments (7 papers), Organ Transplantation Techniques and Outcomes (6 papers), Ferroptosis and cancer prognosis (5 papers) and Catalytic C–H Functionalization Methods (5 papers). The work is most often cited by research in Genetics (341 citations), Rheumatology (381 citations), Hematology (230 citations), Hepatology (117 citations) and Transplantation (38 citations). Zhixian Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ming Jen Tan, Jinquan Cai, E. C. Hsia, Sudha Visvanathan, Mahboob U. Rahman, William Palmer, J Pazdur, Sang‐Cheol Bae, Julie Zrubek and Stephen Hall. Their work appears in journals such as Cytotherapy, Frontiers in Oncology, Stem Cell Research & Therapy, BioMed Research International and Organic Chemistry Frontiers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.